Terazosin
- Product NDC
- 55700-750
- 11-digit product format
- 557000750
- Labeler code
- 55700
- Product ID
- 55700-750_f5b5de5f-c7b6-479b-8e7c-8cdcfee11505
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Terazosin Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Quality Care Products, LLC
- Application
- ANDA075317
- Marketing category
- ANDA
- Marketing start
- 2019-04-26
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55700-750-90 | 55700075090 | 90 CAPSULE in 1 BOTTLE (55700-750-90) | 90 capsule | 2019-04-26 | 0000-00-00 | No | No | Current |